Ardent Health, Inc. (NYSE:ARDT) Given Consensus Rating of “Hold” by Brokerages

Shares of Ardent Health, Inc. (NYSE:ARDT) have been given an average rating of “Hold” by the fourteen research firms that are presently covering the company, Marketbeat.com reports. Three investment analysts have rated the stock with a sell rating, four have given a hold rating and seven have assigned a buy rating to the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $13.0455.

A number of analysts recently weighed in on the stock. UBS Group upped their price target on shares of Ardent Health from $13.00 to $13.50 and gave the stock a “buy” rating in a research report on Thursday, May 7th. Truist Financial raised their price target on shares of Ardent Health from $12.00 to $13.00 and gave the company a “buy” rating in a report on Thursday, August 6th. Zacks Research cut Ardent Health from a “hold” rating to a “strong sell” rating in a research note on Thursday, August 6th. Weiss Ratings downgraded Ardent Health from a “sell (d+)” rating to a “sell (d)” rating in a report on Tuesday, August 11th. Finally, Royal Bank Of Canada raised their price objective on shares of Ardent Health from $12.00 to $13.00 and gave the stock an “outperform” rating in a report on Monday, August 10th.

Ardent Health Stock Down 1.0%

Shares of NYSE:ARDT opened at $10.85 on Tuesday. The stock has a 50-day simple moving average of $10.59 and a 200-day simple moving average of $9.78. The stock has a market capitalization of $1.53 billion, a P/E ratio of 19.73, a PEG ratio of 3.07 and a beta of 0.70. Ardent Health has a 1 year low of $7.71 and a 1 year high of $15.48. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.99 and a current ratio of 2.10.

Ardent Health (NYSE:ARDT) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.12 earnings per share for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.06). Ardent Health had a net margin of 1.22% and a return on equity of 10.35%. The business had revenue of $1.62 billion for the quarter, compared to analyst estimates of $1.59 billion. Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. Equities analysts forecast that Ardent Health will post 0.97 earnings per share for the current year.

Insiders Place Their Bets

In other news, CFO Alfred Lumsdaine bought 10,000 shares of Ardent Health stock in a transaction on Friday, June 5th. The shares were bought at an average price of $8.81 per share, with a total value of $88,100.00. Following the acquisition, the chief financial officer directly owned 329,183 shares in the company, valued at approximately $2,900,102.23. This represents a 3.13% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.90% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Ardent Health

A number of hedge funds have recently added to or reduced their stakes in the business. The Manufacturers Life Insurance Company raised its holdings in shares of Ardent Health by 3.7% during the first quarter. The Manufacturers Life Insurance Company now owns 29,812 shares of the company’s stock worth $255,000 after purchasing an additional 1,072 shares during the period. Geode Capital Management LLC grew its position in shares of Ardent Health by 0.6% during the 2nd quarter. Geode Capital Management LLC now owns 286,848 shares of the company’s stock valued at $3,918,000 after buying an additional 1,769 shares during the last quarter. The Manufacturers Life Insurance Company raised its stake in Ardent Health by 8.3% during the second quarter. The Manufacturers Life Insurance Company now owns 27,530 shares of the company’s stock worth $376,000 after acquiring an additional 2,110 shares during the period. Caitong International Asset Management Co. Ltd lifted its holdings in Ardent Health by 1,177.7% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 2,862 shares of the company’s stock worth $25,000 after acquiring an additional 2,638 shares during the last quarter. Finally, Allworth Financial LP acquired a new position in Ardent Health in the second quarter valued at approximately $28,000.

Ardent Health Company Profile

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.